Related Experiment Videos
Olfaction and Alzheimer's disease.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 1, 1986
Summary
Olfactory dysfunction is a significant early sign in Alzheimer's disease, impacting smell recognition. This highlights its potential role in early diagnosis and understanding disease progression.
Area of Science:
- Neurology
- Neuroscience
- Gerontology
Background:
- Olfactory dysfunction is increasingly recognized as a potential early indicator in neurodegenerative diseases.
- Previous studies suggest impaired smell recognition in Alzheimer's disease (AD) and parkinsonian dementias.
Purpose of the Study:
- To review the clinical and theoretical significance of olfactory disturbances in Alzheimer's disease.
- To discuss the neuroanatomical and neurochemical underpinnings of olfactory deficits in AD.
- To explore the utility of olfactory testing in differential diagnosis.
Main Methods:
- Review of existing preclinical and clinical data on olfaction and Alzheimer's disease.
- Analysis of studies investigating the effects of acetylcholine-related compounds on olfactory function.
- Comparison of olfactory performance in Alzheimer's disease patients versus other dementia cohorts.
Main Results:
- Olfactory dysfunction is consistently reported in Alzheimer's disease.
- Preliminary findings suggest scopolamine may not significantly affect olfactory thresholds.
- Patients with alcoholic and vascular dementia may exhibit better olfactory performance than AD patients, aiding differential diagnosis.
Conclusions:
- Olfactory deficits are a key feature of Alzheimer's disease, with potential diagnostic value.
- The precise neurochemical mechanisms, particularly involving acetylcholine, require further investigation.
- Careful control for cognitive impairment is essential when assessing the impact of aging on olfaction.